Search Results - "LINEHAN, D. C"

Refine Results
  1. 1

    Outcomes analysis of laparoscopic resection of pancreatic neoplasms by PIERCE, R. A, SPITLER, J. A, HAWKINS, W. G, STRASBERG, S. M, LINEHAN, D. C, HALPIN, V. J, EAGON, J. C, BRUNT, L. M, FRISELLA, M. M, MATTHEWS, B. D

    Published in Surgical endoscopy (01-04-2007)
    “…Experience with laparoscopic resection of pancreatic neoplasms remains limited. The purpose of this study is to critically analyze the indications for and…”
    Get full text
    Journal Article
  2. 2

    Myeloid-derived suppressor cells: general characteristics and relevance to clinical management of pancreatic cancer by Goedegebuure, P, Mitchem, J B, Porembka, M R, Tan, M C B, Belt, B A, Wang-Gillam, A, Gillanders, W E, Hawkins, W G, Linehan, D C

    Published in Current cancer drug targets (01-07-2011)
    “…Recent studies describe a heterogeneous population of cells of the myeloid lineage, termed myeloid derived suppressor cells (MDSC), which are observed with…”
    Get more information
    Journal Article
  3. 3

    Surgical margin in hepatic resection for colorectal metastasis : A critical and improvable determinant of outcome by CADY, B, JENKINS, R. L, LAVIN, P, LINEHAN, D. C, STEELE, G. D, LEWIS, W. D, STONE, M. D, MCDERMOTT, W. V, JESSUP, J. M, BOTHE, A, LALOR, P, LOVETT, E. J

    Published in Annals of surgery (01-04-1998)
    “…To update the analysis of technical and biologic factors related to hepatic resection for colorectal metastasis in a large single-institution series to…”
    Get full text
    Journal Article
  4. 4

    Influence of Biologic Factors and Anatomic Site in Completely Resected Liposarcoma by LINEHAN, D. C, LEWIS, J. J, LEUNG, D, BRENNAN, M. F

    Published in Journal of clinical oncology (01-04-2000)
    “…Soft tissue sarcoma (STS) encompasses a group of neoplasms that are anatomically and biologically diverse. Retroperitoneal/visceral (RP/V) tumors have a poorer…”
    Get full text
    Journal Article
  5. 5

    Breast and Ovarian Cancer-Specific Cytotoxic T Lymphocytes Recognize the Same HER2/Neu-Derived Peptide by Peoples, George E., Goedegebuure, Peter S., Smith, Roy, Linehan, David C., Yoshino, Ichiro, Eberlein, Timothy J.

    “…The identification of antigenic peptides presented on the tumor cell surface by HLA class I molecules and recognized by tumor-specific cytotoxic T lymphocytes…”
    Get full text
    Journal Article
  6. 6

    Sentinel lymph node biopsy in breast cancer: unfiltered radioisotope is superior to filtered by Linehan, David C, Hill, Arnold D.K, Tran, Kathy N, Yeung, Henry, Yeh, Samuel D.J, Borgen, Patrick I, Cody, Hiram S

    “…Background: The combination of gamma-probe radiolocalization and blue-dye mapping of sentinel lymph nodes (SLNs) has been advocated as the most accurate method…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Mechanisms of radiocolloid localization in sentinel node biopsy by Linehan, D C, Eberlein, T J

    Published in Annals of surgical oncology (01-03-2000)
    “…IntroductionCytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) is an established treatment for pseudomyxoma peritonei resulting…”
    Get full text
    Journal Article
  9. 9

    Intradermal radiocolloid and intraparenchymal blue dye injection optimize sentinel node identification in breast cancer patients by Linehan, D C, Hill, A D, Akhurst, T, Yeung, H, Yeh, S D, Tran, K N, Borgen, P I, Cody, 3rd, H S

    Published in Annals of surgical oncology (01-07-1999)
    “…Radiotracer and blue dye mapping of sentinel lymph nodes (SLN) have been advocated as accurate methods to stage the clinically negative axilla in breast cancer…”
    Get full text
    Journal Article
  10. 10

    Immunoregulatory effects of CD4 + T helper subsets in human melanoma by Lee, Kyung-Yung, Goedegebuure, Peter S., Linehan, David C., Eberlein, Timothy J.

    Published in Surgery (01-04-1995)
    “…Background. The elucidation of CD4 + T helper (Th) cell traits is important for the understanding of immunoregulatory mechanisms in patients with cancer, in…”
    Get full text
    Journal Article
  11. 11

    Magnetic resonance imaging facilitates breast conservation for occult breast cancer by Olson, Jr, J A, Morris, E A, Van Zee, K J, Linehan, D C, Borgen, P I

    Published in Annals of surgical oncology (01-07-2000)
    “…Occult primary breast cancer, i.e., isolated axillary adenocarcinoma without detectable tumor in the breast by either physical exam or mammography, represents…”
    Get full text
    Journal Article
  12. 12

    Induction of Antigen-Specific CTL by Recombinant HIV Trans-Activating Fusion Protein-Pulsed Human Monocyte-Derived Dendritic Cells by Tanaka, Yoshiyuki, Dowdy, Steven F, Linehan, David C, Eberlein, Timothy J, Goedegebuure, Peter S

    Published in The Journal of immunology (1950) (01-02-2003)
    “…Several systems have been tested for introduction of Ags into human dendritic cells (DC). Most of them to date, however, are complex and possess limited…”
    Get full text
    Journal Article
  13. 13

    Tumor-specific and HLA-A2-restricted cytolysis by tumor-associated lymphocytes in human metastatic breast cancer by Linehan, DC, Goedegebuure, PS, Peoples, GE, Rogers, SO, Eberlein, TJ

    Published in The Journal of immunology (1950) (01-11-1995)
    “…A tumor-specific cytotoxic T lymphocyte (CTL) immune response has been well documented in melanoma, renal cell carcinoma, and ovarian cancer. Conflicting…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17

    The HER2/neu-derived peptide p654-662 is a tumor-associated antigen in human pancreatic cancer recognized by cytotoxic T lymphocytes by Peiper, M, Goedegebuure, P S, Linehan, D C, Ganguly, E, Douville, C C, Eberlein, T J

    Published in European journal of immunology (01-05-1997)
    “…The protooncogene HER2/neu encodes a 185-kDa transmembrane protein with extensive homology to the epidermal growth factor receptor. It is overexpressed in…”
    Get more information
    Journal Article
  18. 18

    In vitro stimulation of ovarian tumour-associated lymphocytes with a peptide derived from HER2/ neu induces cytotoxicity against autologous tumour by Linehan, D.C., Peoples, G.E., Hess, D.T., Summerhayes, I.C., Parikh, A.S., Goedegebuure, P.S., Eberlein, T.J.

    Published in Surgical oncology (01-02-1995)
    “…The proto-oncogene HER2/ neu encodes for a 185 kDa transmembrane protein with extensive homology to the epidermal growth factor (EGF) receptor. We have…”
    Get full text
    Journal Article
  19. 19

    Tumor-derived TGF-β Mediates Conversion of CD4+Foxp3+ Regulatory T Cells in a Murine Model of Pancreas Cancer by MOO-YOUNG, Tricia A, LARSON, Justin W, BELT, Brian A, TAN, Marcus C, HAWKINS, William G, EBERLEIN, Timothy J, GOEDEGEBUURE, Peter S, LINEHAN, David C

    Published in Journal of immunotherapy (1997) (2009)
    “…CD4+25+Foxp3+ regulatory T cells (Treg) play a critical role in the induction of tolerance to tumor-associated antigens and suppression of antitumor immunity…”
    Get full text
    Journal Article
  20. 20

    Vaccine therapy for cancer by Linehan, D C, Goedegebuure, P S, Eberlein, T J

    Published in Annals of surgical oncology (01-03-1996)
    “…Tumor-specific cytotoxic T-lymphocytes (CTLs) can be isolated from the solid tumors, draining lymph nodes, metastatic effusions, and peripheral blood of cancer…”
    Get full text
    Journal Article